drugset / Trial / NCT01656330
A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers
RandomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to assess the use of 2 different Prothrombin Complex Concentrates (PCCs) on their ability to reverse (normalize) the pharmacodynamic effects of rivaroxaban in healthy adult volunteers.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beriplex P/N | Unknown | 50 iu/kg | Intravenous |
| Subject | FACTOR IX COMPLEX | Unknown | 50 iu/kg | Intravenous |
| Subject | Rivaroxaban | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.